Primarily driven by increasing instances of fractures due to road accidents and sports-related injuries, the global market for orthopaedic trauma devices is anticipated to expand at a compound annual growth rate (CAGR) of 6.8% over the next decade.
By the end of 2028, the orthopaedic trauma devices market is estimated to attain global revenues beyond $14bn.
As per the research presented in a recently published report by Future Market Insights (FMI) titled ‘Orthopedic Trauma Devices Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment, 2018 – 2028’, the market will also continue to be driven by the presence of some local players within respective regional markets.
A research analyst at FMI said: “While the advent of 3D printing technology is likely to present the market a heap of new growth opportunities in 3D printed orthopaedic implants, another significant opportunity lies in the popularly trending reverse shoulder arthroplasty. The rise of digital orthopaedics will continue to fuel market growth through to 2028.”
Based on the regional analysis, the global orthopaedic trauma devices market will continue to be dominated by North America, which currently accounts for a major portion of the total revenue. With around a 48% share observed in 2017, North America’s orthopaedic trauma devices market is estimated to attain a value in excess of $6bn by the end of 2028.
Western Europe is also identified to be a key market, holding the second largest position in terms of value. However, manufacturers will discover attractive opportunities in developing economies such as the Asia Pacific (APAC), Latin America, and the Middle East and Africa (MEA).
Among the emerging regional markets, the APAC excluding China and Japan (APECJ) is likely to emerge at a relatively higher pace, followed by the MEA. China is expected to be the most lucrative market due to the highest estimated CAGR value over the 2018-2028 period. A strong presence of key companies will reportedly uplift the markets in North America and China.
A majority of the key companies operating in the global orthopaedic trauma market are opting for strategic mergers and acquisitions alongside new product launches. According to the report, most of the revenue is contributed by the tier one companies, followed by the tier three players. Tier one includes DePuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, and Smith & Nephew, which collectively represent nearly 70% share of the total market revenue. Among these, DePuy and Stryker are expected to continue to remain the top players worldwide over the next decade.
Tier three accounts for a relatively decent revenue share and includes brands such as Arthrex, RTISurgical, Medartis, Integra LifeSciences Corporation, Japan MDM, S. H. Pitkar Orthotools, Weigao Group Co, and Invibio.
Others operating in the global orthopaedic trauma devices market include Johnson & Johnson Services, Wright Medical Group, B. Braun Melsungen, Orthofix International and OsteoMed. Growing outpatient surgical procedure demand and boosting funds for delivery of the top-notch trauma care are foreseen to collectively create a lucrative pool of opportunities for the leading bunch of companies in the global marketplace. The market is also witnessing the development of novel and effective products for use in trauma care, which stands to be another important opportunity.
To request a sample report, click here.
To find out more information about report methodology, click here.